x

Search for a clinical trial

* (*) mandatory field

REGO-SARC: Activity and Safety of Regorafenib in Patients With Metastatic Soft Tissue Sarcoma Previously Treated With Anthracycline-based Chemotherapy: a Multinational, Randomized, Phase II, Placebo-controlled Trial - AT

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : European
  • Sponsor : Centre oscar lambret
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • Pr Thomas BRODOWICZ
  • Klinische Abteilung für Onkologie
  • Universitätsklinik für Innere Medizin I
  • Allgemeines Krankenhaus der Stadt Wien
  • Währinger Gürtel 18-20
  • 1097 WIEN
  • AUSTRIA
  • More information
  • Phone  : +43 (0)1 40400 44450
  • Fax  : -
  • Website
  • Sponsor of clinical trial

  • CENTRE OSCAR LAMBRET
  • Direction de la Recherche Clinique et de l'Innovation (DRCI) - Centre Oscar Lambret
  • CLCC Oscar Lambret
  • 3 Rue Frédéric Combemale BP 307
  • 59020 LILLE CEDEX
  • FRANCE
  • More information
  • Phone  : 33 (0)3 20 29 59 35
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: March 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.